Your browser doesn't support javascript.
loading
The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells.
Gao, Hai-Ling; Cui, Qingbin; Wang, Jing-Quan; Ashby, Charles R; Chen, Yanchun; Shen, Zhi-Xin; Chen, Zhe-Sheng.
Afiliación
  • Gao HL; Department of Histology and Embryology, Weifang Medical University, Weifang, Shandong, China.
  • Cui Q; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
  • Wang JQ; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
  • Ashby CR; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
  • Chen Y; Department of Histology and Embryology, Weifang Medical University, Weifang, Shandong, China.
  • Shen ZX; Affiliated Hospital of Weifang Medical University, Weifang, Shandong, China.
  • Chen ZS; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, United States.
Front Pharmacol ; 14: 1235285, 2023.
Article en En | MEDLINE | ID: mdl-37521473
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza